Literature DB >> 19853714

[Heart rate variability. Applications in psychiatry].

D Servant1, R Logier, Y Mouster, M Goudemand.   

Abstract

BACKGROUND: The autonomic nervous system sends messages through the sympathetic and parasympathetic nervous system. The sympathetic nervous system innervates the cardioaccelerating center of the heart, the lungs (increased ventilatory rhythm and dilatation of the bronchi) and the non-striated muscles (artery contraction). It releases adrenaline and noradrenaline. As opposed to the sympathetic nervous system, it innervates the cardiomoderator center of the heart, the lungs (slower ventilatory rhythm and contraction of the bronchi) and the non-striated muscles (artery dilatation). It uses acetylcholine (ACh) as its neurotransmitter. Sympathetic and parasympathetic divisions function antagonistically to preserve a dynamic modulation of vital functions. These systems act on the heart respectively through the stellar ganglion and the vagus nerve. The interaction of these messages towards the sinoauricular node is responsible for normal cardiac variability, which can be measured by monitoring heart rate variability (HRV). Heart rate is primarily controlled by vagal activity. Sensorial data coming from the heart are fed back to the central nervous system. HRV is an indicator of both how the central nervous system regulates the autonomic nervous system, and of how peripheral neurons feed information back to the central level. HRV measures are derived by estimating the variation among a set of temporally ordered interbeat intervals. The state of perfect symmetry, which, in medical parlance, is called respiratory sinus arrhythmia (RSA), can be described as a state of cardiac coherence. Obtaining a series of interbeat intervals requires a continuous measure of heart rate, typically electrocardiography (ECG). Commercially available software is then used to define the interbeat intervals within an ECG recording. LITERATURE
FINDINGS: The autonomic nervous system is highly adaptable and allows the organism to maintain its balance when experiencing strain or stress. Conversely, a lack of flexibility and a rigid system can lead to somatic and psychological pathologies. Several studies have shown a link between reduced HRV in postmyocardial infarction patients and increased risk for adverse cardiovascular events, including ventricular arrhythmias and sudden death. Recently, studies indicate that patients with depression and anxiety disorders exhibit abnormally low HRV compared with non-psychiatric controls. Reduced HRV seems indicate decreased cardiac vagal tone and elevated sympathetic activity in anxious and depressive patients and would reflect deficit in flexibility of emotional physiological mechanisms. A few studies have also revealed that biofeedback using respiratory control, relaxation and meditation techniques can increase HRV. For now, there is insufficient data to determine if paced respiration or subjective relaxation is necessary or sufficient for the efficacy of HRV biofeedback. Although the literature is modest, this review suggests that the use of biofeedback with relaxation and meditation approaches may result in increased HRV and parasympathetic activity. Limitations of the review literature have also been considered to identify areas for future research.

Entities:  

Mesh:

Year:  2008        PMID: 19853714     DOI: 10.1016/j.encep.2008.06.016

Source DB:  PubMed          Journal:  Encephale        ISSN: 0013-7006            Impact factor:   1.291


  14 in total

1.  Heart rate variability and pre-competitive anxiety in BMX discipline.

Authors:  Manuel Mateo; Cristina Blasco-Lafarga; Ignacio Martínez-Navarro; José F Guzmán; Mikel Zabala
Journal:  Eur J Appl Physiol       Date:  2011-04-19       Impact factor: 3.078

2.  Upper gastrointestinal complications following ablation therapy for atrial fibrillation.

Authors:  S-Y Park; M Camilleri; D Packer; K Monahan
Journal:  Neurogastroenterol Motil       Date:  2017-05-19       Impact factor: 3.598

3.  Power spectrum scale invariance identifies prefrontal dysregulation in paranoid schizophrenia.

Authors:  Anca R Radulescu; Denis Rubin; Helmut H Strey; Lilianne R Mujica-Parodi
Journal:  Hum Brain Mapp       Date:  2011-05-12       Impact factor: 5.038

4.  Minimalistic toy robot to analyze a scenery of speaker-listener condition in autism.

Authors:  Irini Giannopulu; Valérie Montreynaud; Tomio Watanabe
Journal:  Cogn Process       Date:  2016-02-12

5.  Dysregulation of the autonomous nervous system in patients with temporomandibular disorder: a pupillometric study.

Authors:  Annalisa Monaco; Ruggero Cattaneo; Luca Mesin; Irma Ciarrocchi; Fabrizio Sgolastra; Davide Pietropaoli
Journal:  PLoS One       Date:  2012-09-18       Impact factor: 3.240

Review 6.  Analysis of Heart Rate Variability and Implication of Different Factors on Heart Rate Variability.

Authors:  Reena Tiwari; Ravindra Kumar; Sujata Malik; Tilak Raj; Punit Kumar
Journal:  Curr Cardiol Rev       Date:  2021

7.  Functional Ser205Leu polymorphism of the nerve growth factor receptor (NGFR) gene is associated with vagal autonomic dysregulation in humans.

Authors:  Chuan-Chia Chang; Wen-Hui Fang; Hsin-An Chang; San-Yuan Huang
Journal:  Sci Rep       Date:  2015-08-17       Impact factor: 4.379

8.  Effect and mechanism of fluoxetine on electrophysiology in vivo in a rat model of postmyocardial infarction depression.

Authors:  Jinjun Liang; Xiaoran Yuan; Shaobo Shi; Fang Wang; Yingying Chen; Chuan Qu; Jingjing Chen; Dan Hu; Bo Yang
Journal:  Drug Des Devel Ther       Date:  2015-02-10       Impact factor: 4.162

9.  Decreased neuroautonomic complexity in men during an acute major depressive episode: analysis of heart rate dynamics.

Authors:  S J-J Leistedt; P Linkowski; J-P Lanquart; J E Mietus; R B Davis; A L Goldberger; M D Costa
Journal:  Transl Psychiatry       Date:  2011-07-26       Impact factor: 6.222

Review 10.  Telemonitoring with respect to mood disorders and information and communication technologies: overview and presentation of the PSYCHE project.

Authors:  Hervé Javelot; Anne Spadazzi; Luisa Weiner; Sonia Garcia; Claudio Gentili; Markus Kosel; Gilles Bertschy
Journal:  Biomed Res Int       Date:  2014-06-24       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.